Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis (AG10) | サターラ

Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis (AG10)

関連コンテンツ

Behind the Science: A Conversation with Katrina Hui

How the US FDA MIDD paired pilot program helps sponsors

Behind the Science: A Conversation with Lamia Sid-Otmane

Driving Innovation in Pharmacometrics: An Interview with Wynand Smythe, Associate Director at Certara

Powered by Translations.com GlobalLink Web Software